Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Glutamine as a pathogenic factor in hepatic encephalopathy.

J Albrecht1, M Dolińska

  • 1Department of Neurotoxicology, Medical Research Center, Polish Academy of Sciences, Warsaw, Poland. jalb@cmdik.pan.pl

Journal of Neuroscience Research
|July 4, 2001
PubMed
Summary

Hepatic encephalopathy (HE) is linked to high ammonia levels in the brain, causing increased glutamine (Gln) synthesis. Reducing brain Gln levels may alleviate HE symptoms and complications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

First Measurement of the Z→μ^{+}μ^{-} Angular Coefficients in the Forward Region of pp Collisions at sqrt[s]=13  TeV.

Physical review letters·2022
Same author

Angular Analysis of D^{0}→π^{+}π^{-}μ^{+}μ^{-} and D^{0}→K^{+}K^{-}μ^{+}μ^{-} Decays and Search for CP Violation.

Physical review letters·2022
Same author

Tests of Lepton Universality Using B^{0}→K_{S}^{0}ℓ^{+}ℓ^{-} and B^{+}→K^{*+}ℓ^{+}ℓ^{-} Decays.

Physical review letters·2022
Same author

Observation of the Decay Λ_{b}^{0}→Λ_{c}^{+}τ^{-}ν[over ¯]_{τ}.

Physical review letters·2022
Same author

Observation of Two New Excited Ξ_{b}^{0} States Decaying to Λ_{b}^{0}K^{-}π^{+}.

Physical review letters·2022
Same author

Measurement of the Nuclear Modification Factor and Prompt Charged Particle Production in p-Pb and pp Collisions at sqrt[s_{NN}]=5  TeV.

Physical review letters·2022

Area of Science:

  • Neuroscience
  • Biochemistry
  • Hepatology

Background:

  • Hepatic encephalopathy (HE) is a neuropsychiatric complication of acute or chronic liver dysfunction, characterized by hyperammonemia.
  • Ammonium ions cross the blood-brain barrier, leading to increased brain glutamine (Gln) synthesis via glutamine synthetase (GS).
  • Elevated Gln levels are implicated in various HE manifestations, including cerebral edema and altered brain energy metabolism.

Purpose of the Study:

  • To investigate the role of increased brain glutamine (Gln) synthesis in the pathogenesis of hepatic encephalopathy (HE).
  • To explore the potential therapeutic benefits of reducing brain Gln accumulation in HE models.

Main Methods:

  • Experimental models of hepatic encephalopathy (HE) in rats.
  • Administration of a glutamine synthetase (GS) inhibitor, methionine sulfoximine, to reduce brain Gln content.

Related Experiment Videos

  • Observation of changes in HE manifestations following Gln reduction.

    • Main Results:

    • Experimental data suggest that elevated Gln synthesis and accumulation in the brain contribute significantly to HE pathology.
    • In acute liver failure models, Gln-induced osmotic effects are linked to cerebral edema and associated circulatory and ionic disturbances.
    • In chronic HE, Gln impairs cerebral energy metabolism and alters aromatic amino acid transport, with tryptophan metabolites implicated in HE.

    Conclusions:

    • Glutamine (Gln) plays a critical role in the development and manifestation of hepatic encephalopathy (HE).
    • Reducing brain Gln levels through GS inhibition can ameliorate HE symptoms in experimental models.
    • Targeting Gln synthesis presents a potential therapeutic strategy for managing HE.